Latest Schedule 13G passive stakes

NYSE
State Street Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.6% of Broadstone Net Lease Inc.'s common stock as of June 30, 2026.
NYSE
State Street Corporation has updated its beneficial ownership filing for Bristol-Myers Squibb, reporting a significant aggregate holding.
NYSE
State Street Corporation has updated its beneficial ownership filing for Bristol-Myers Squibb, reporting a significant aggregate holding.
NYSE
State Street Corporation has disclosed beneficial ownership of 5% of Black Hills Corp's common stock as of June 30, 2026.
NYSE
State Street Corporation has disclosed beneficial ownership of 5% of Black Hills Corp's common stock as of June 30, 2026.
NYSE
State Street Corporation has updated its Schedule 13G filing to reflect its beneficial ownership of 15,191,098 shares, or approximately 6%, of BioCryst Pharmaceuticals Inc. common stock as of June 30, 2026.
NASDAQ
State Street Corporation has updated its Schedule 13G filing to reflect its beneficial ownership of 15,191,098 shares, or approximately 6%, of BioCryst Pharmaceuticals Inc. common stock as of June 30, 2026.
NYSE
State Street Corporation has updated its beneficial ownership filing for Becton Dickinson & Co., reporting a significant stake.
NYSE
State Street Corporation has updated its beneficial ownership filing for Becton Dickinson & Co., reporting a significant stake.
NYSE
State Street Corporation has updated its beneficial ownership filing for Ball Corp, reporting a significant stake in the company's common stock.
NYSE
State Street Corporation has updated its beneficial ownership filing for Ball Corp, reporting a significant stake in the company's common stock.
NYSE
State Street Corporation has reported beneficial ownership of 5.3% of Axos Financial Inc.'s common stock as of June 30, 2026.
NYSE
State Street Corporation has reported beneficial ownership of 5.3% of Axos Financial Inc.'s common stock as of June 30, 2026.
NYSE
State Street Corporation has disclosed beneficial ownership of 5.3% of Avery Dennison Corp.'s common stock as of June 30, 2026.
NYSE
State Street Corporation has disclosed beneficial ownership of 5.3% of Avery Dennison Corp.'s common stock as of June 30, 2026.
NYSE
State Street Corporation has disclosed beneficial ownership of 5.5% of Avalo Therapeutics Inc.'s common stock as of June 30, 2026.
NASDAQ
State Street Corporation has disclosed beneficial ownership of 5.5% of Avalo Therapeutics Inc.'s common stock as of June 30, 2026.
NASDAQ
State Street Corporation has disclosed beneficial ownership of 5.1% of Automatic Data Processing Inc. common stock as of June 30, 2026.
NYSE
State Street Corporation has disclosed beneficial ownership of 5.1% of Automatic Data Processing Inc. common stock as of June 30, 2026.
NYSE
State Street Corporation has updated its beneficial ownership filing for Arcutis Biotherapeutics Inc., reporting a significant holding of common stock.
NASDAQ
State Street Corporation has updated its beneficial ownership filing for Arcutis Biotherapeutics Inc., reporting a significant holding of common stock.
NYSE
State Street Corporation has reported beneficial ownership of 6.4% of Archer Aviation Inc.'s common stock as of June 30, 2026.
NYSE
State Street Corporation has reported beneficial ownership of 6.4% of Archer Aviation Inc.'s common stock as of June 30, 2026.
NYSE
State Street Corporation has disclosed beneficial ownership of 6% of Annvon Inc.'s common stock as of June 30, 2026.
NASDAQ
State Street Corporation has disclosed beneficial ownership of 6% of Annvon Inc.'s common stock as of June 30, 2026.
NYSE
State Street Corporation has disclosed beneficial ownership of 5.2% of Ameris Bancorp's common stock as of June 30, 2026.
NYSE
State Street Corporation has disclosed beneficial ownership of 5.2% of Ameris Bancorp's common stock as of June 30, 2026.
NYSE
State Street Corporation has updated its beneficial ownership filing for American Healthcare REIT Inc., reporting a 4.3% stake.
NYSE
State Street Corporation has updated its beneficial ownership filing for American Healthcare REIT Inc., reporting a 4.3% stake.
NYSE
State Street Corporation has disclosed beneficial ownership of 5.8% of Ambarella Inc.'s common stock as of June 30, 2026.